Psoriasis
Chronic, immune-mediated inflammatory skin disease driven by IL-23/Th17-axis dysregulation, presenting as well-demarcated erythematous plaques with silvery scale; the most common presentation is chronic plaque psoriasis, though pustular and erythrodermic subtypes also occur.
Phase 1/2 and later readouts in Psoriasis, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Total attributable cost
$28.4B
$3,592/patient
Drug spend
Not yet sourced
All severities, physician-diagnosed history (2023 NHIS) · US